Nov 30, 2022 / 02:15PM GMT
Liisa Ann Bayko - Evercore ISI Institutional Equities, Research Division - MD & Fundamental Research Analyst
Hi there. This is Liisa Bayko, biotech analyst at Evercore ISI. Welcome to HealthCONx day 2. We're very pleased to be hosting a nice juicy 45-minute session with Vertex. And we've got Stuart Arbuckle, which I think is just like a great person to be talking to today because we do have a lot of commercial questions, and you are the COO. And so you know all about operations and commercialization, and we have a lot of questions there. So I don't -- I think just to frame it up, maybe just give us a quick snapshot of Vertex to frame the conversation for anyone who may be kind of needing a bit of a refresher that's on the line.
Stuart A. Arbuckle - Vertex Pharmaceuticals Incorporated - Executive VP & COO
All right. Certainly, Liisa. Well, firstly, thank you to you and to Evercore ISI for inviting us. Really pleased to be here. Hello to everybody who is on the webcast. Just a reference, we will be making forward-looking statements on our call. Obviously,
Vertex Pharmaceuticals Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers